Breast cancer-treatment for the future based on lessons from the past

American Journal of Surgery

Volumn 184, Issue 6, 2002, Pages 477-483

  Edney, James A ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; ARIMEDEX; FULVESTRANT; RALOXIFENE; TAMOXIFEN; TAXANE DERIVATIVE;

BREAST CANCER; BREAST RECONSTRUCTION; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SUSCEPTIBILITY; CANCER THERAPY; CAREER; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONFERENCE PAPER; HUMAN; LASER SURGERY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MEDICAL LITERATURE; MEDICAL SOCIETY; NIPPLE; PARTIAL MASTECTOMY; PRIORITY JOURNAL; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; FORECASTING; HUMANS;

EID: 0036915806     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(02)01126-1     Document Type: Conference Paper

References (32)

1. Halsted W.S. A clinical and histological study of certain adenocarcinomata of the breast and a brief consideration of the supraclavicular operations for cancer of the breast from 1889 to 1898 at Johns Hopkins Hospital. Trans Am Surg Assoc. 16:1898;144-181.
2. Halsted W.S. The results of operations for the cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Johns Hopkins Hosp Report. 4:1894;297-350.
3. Mustakallio S. Treatment of breast cancer by tumor extirpation and roentgen therapy instead of radical operation. J Fac Radio. 6:1954;23.
4. Fisher B., Fisher E.R. The interrelationship of hematogenous and lymphatic tumor cell dissemination. Surg Gynecol Obstet. 122:1966;791-798.
5. Fisher B., Anderson S., Redmond C.K., et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 333:1995;1456-1461.
6. Elliott L.F., Eskenazi L., Beegle P.H., et al. Immediate TRAM flap breast reconstruction 128 consecutive cases . Plast Reconstr Surg. 92:1992;217-227.
7. Schain W.S., Wellisch D.K., Pasnau R.O. The sooner the better a study of psychological factors in women undergoing immediate versus delayed breast reconstruction . Am J Psychol. 40:1985;142-150.
8. National Institutes of Health/National Cancer Institute consensus development meeting on breast cancer issues and recommendations . J Natl Cancer Inst. 60:1978;1523-1524.
9. Shapiro S., Strax P., Venet L., et al. Changes in 5-year breast cancer mortality in a breast cancer screening program. Seventeenth National Cancer Conference Proceedings, American Cancer Society, January:1974;663-678.
10. Dales L.G., Friedman G.D., Collen M.F. Evaluating periodic multiphasic health check-ups a controlled trial . J Chronic Dis. 32:1979;385-404.
11. Tabar L., Gad A. Screening for breast cancer the Swedish trial . Radiology. 138:1981;219-222.
12. Lagios M.D. Duct carcinoma in situ pathology and treatment . Surg Clin North Am. 70:1990;853-871.
13. Silverstein M.J., Cohlan B., Gierson E.D., et al. Duct carcinoma in situ 227 cases without microinvasion . Eur J Cancer. 28:1992;630-634.
14. Velanovich V. Stereotactic breast biopsies - choices, choices. Breast Diseases. Vol. 12. No. 2:2001;Year Book Quarterly, Chicago.
15. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
16. Wooster R., Bignell G., Lancaster J., et al. Identification of the breast cancer susceptibility gene BRCA1. Nature. 378:1995;789-792.
17. Polychemotherapy for early breast cancer an overview of the randomized trials . Lancet. 352:1998;930-942.
18. Tamoxifen for early breast cancer an overview of the randomized trials . Lancet. 351:1998;1451-1467.
19. Bezwoda W.R. Randomized controlled trial of high-dose chemotherapy (HD-CNVp) vs standard dose (CAF) chemotherapy for high-risk, surgically treated primary breast cancer. Proc Am Soc Clin Oncol. 18:1999;2a. [abstract 4].
20. Peters W.P., Rosner G., Vredenburgh J., et al. A prospective, randomized comparison of two doses of combination alkylating agents as consolidation after CAF in high-risk primary breast cancer involving ten or more axillary lymph nodes preliminary results of CALGB 9082/SWOG 9114/NCIC MA-13 . [abstract 2] Proc Am Soc Clin Oncol. 18:1999;la.
21. Results from a randomized adjuvant breast cancer study with high-dose chemotherapy with CTCb supported by autologous bone marrow stem cells vs dose-escalated and tailored FEC therapy. Proc Am Soc Clin Oncol. 18:1999;2a. [abstract 3].
22. Krag D., Weaver D., Ashikaga T., Moffat F., et al. The sentinel node in breast cancer, a multicenter validation study. N Engl J Med. 339:1998;941-946.
23. Ollila D.W., Brennan M.B., Giuliano A.E. The role of intraoperative lymphatic mapping and sentinel lymphadenectomy in the management of patients with breast cancer. Adv Surg. 32:1999;349-364.
24. Cox C.E., Bass S.S., Boulware D., et al. Implementation of new surgical technology outcome measures for lymphatic mapping of breast carcinoma . Ann Surg Oncol. 6:1999;553-561.
25. Leitch A.M. What's new in surgical oncology. J Am Coll Surg. 192:2001;624-639.
26. Fisher B., Costantino J.P., Wickerham D.L., et al. Tamoxifen for prevention of breast cancer report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study . J Natl Cancer Inst. 90:1998;1371-1388.
27. Greenlee R.T., Hill-Harmon M.B., Murray T., et al. Cancer Statistics, 2001. CA Cancer J Clin. 51:2001;15-36.
28. Byers T., Mouchawar J., Marks J., et al. The American Cancer Society challenge goals how far can cancer rates decline in the U.S. by the year 2015? Cancer. 86:(4):1999;715-727.
29. Tabar L., Duffy S.W., Vitak B., et al. The natural history of breast carcinoma what have we learned from screen? Cancer. 86:1999;449-462.
30. Michaelson J.S., Kopans D.B., Cady B. The breast carcinoma screening interval is important. Cancer. 88:2000;1282-1284.
31. Dooley W.C. Endoscopic visualization of breast tumors. JAMA. 284:2000;1518. [letter].
32. Rogan E., Stack D., Edney J.A., et al. GC/MS analysis of catechol estrogen metabolites in breast tissue samples. Proceedings of the Department of Defense Breast Cancer Research Program Era of Hope Meeting, Washington, DC, October 31-November 4:1997;743-744.